Kaisa Health Group Holdings Limited (HK:0876)
:0876
Want to see HK:0876 full AI Analyst Report?
0876 Stock Chart & Stats
HK$0.09
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.09
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.02 - HK$0.22
Previous CloseN/A
Volume60.00K
Average Volume (3M)76.64M
Market Cap
HK$302.53M
Enterprise Value-HK$87.87M
Total Cash (Recent Filing)HK$109.60M
Total Debt (Recent Filing)HK$13.46M
Price to Earnings (P/E)―
Beta1.31
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding5,042,139,000
10 Day Avg. Volume53,429,215
30 Day Avg. Volume76,644,739
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.88
Price to Sales (P/S)2.54
P/FCF Ratio-6.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Conservative Balance SheetLow reported debt relative to equity gives the company structural resilience while operating losses persist. This conservatism reduces near-term solvency risk, preserves borrowing capacity and provides flexibility to raise funds or restructure without immediate liquidity pressure.
Underlying Gross MarginA still-reasonable gross margin suggests the core product economics and pricing structure retain intrinsic strength. If revenue stabilizes and fixed costs are managed, this margin base supports recovery of operating profitability over multiple quarters rather than depending on short-term swings.
Healthcare / Medical Instruments ExposureOperating in medical instruments and supplies aligns the company with a structurally stable demand sector. Healthcare equipment demand tends to be less cyclical, supporting secular revenue opportunities and providing a more durable end-market tailwind if execution and product competitiveness improve.
Bears Say
Declining Revenue And Volatile ProfitabilitySustained revenue contraction and repeated swings to large losses indicate the business is failing to scale or retain customers. Over several quarters this erodes operating leverage, undermines reinvestment capacity, and increases the structural difficulty of returning to consistent profitability.
Persistent Negative Cash FlowConsistent operating and free cash flow deficits create a structural funding gap that raises reliance on external financing or asset sales. Over a multi-quarter horizon, ongoing cash burn can force dilutive capital raises or cutbacks that impair long-term growth and strategic options.
Eroding Assets, Equity & Negative ROEDeclining asset and equity bases with negative ROE signal capital erosion: the company is destroying shareholder value. This weakens the balance-sheet buffer, limits capacity to invest in product development or distribution, and raises the risk of future dilution to shore up capital.
Kaisa Health Group Holdings Limited News
0876 FAQ
What was Kaisa Health Group Holdings Limited’s price range in the past 12 months?
Kaisa Health Group Holdings Limited lowest stock price was HK$0.02 and its highest was HK$0.22 in the past 12 months.
What is Kaisa Health Group Holdings Limited’s market cap?
Kaisa Health Group Holdings Limited’s market cap is HK$302.53M.
When is Kaisa Health Group Holdings Limited’s upcoming earnings report date?
Kaisa Health Group Holdings Limited’s upcoming earnings report date is Sep 02, 2026 which is in 79 days.
How were Kaisa Health Group Holdings Limited’s earnings last quarter?
Kaisa Health Group Holdings Limited released its earnings results on Mar 25, 2026. The company reported -HK$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.007.
Is Kaisa Health Group Holdings Limited overvalued?
According to Wall Street analysts Kaisa Health Group Holdings Limited’s price is currently Overvalued.
Does Kaisa Health Group Holdings Limited pay dividends?
Kaisa Health Group Holdings Limited pays a Notavailable dividend of HK$0.037 which represents an annual dividend yield of N/A. See more information on Kaisa Health Group Holdings Limited dividends here
What is Kaisa Health Group Holdings Limited’s EPS estimate?
Kaisa Health Group Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kaisa Health Group Holdings Limited have?
Kaisa Health Group Holdings Limited has 5,042,139,000 shares outstanding.
What happened to Kaisa Health Group Holdings Limited’s price movement after its last earnings report?
Kaisa Health Group Holdings Limited reported an EPS of -HK$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Kaisa Health Group Holdings Limited?
Currently, no hedge funds are holding shares in HK:0876
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kaisa Health Group Holdings Limited
Kaisa Health Group Holdings Limited operates as an investment holding company, primarily focused on the manufacturing and global distribution of dental prosthetics across the People's Republic of China and international markets. Its comprehensive product line includes items such as crowns, bridges, full and partial removable dentures, dental implants, and full-cast restorations. The company also delivers public health and general medical services. Moreover, the group's activities extend to holding investments in convertible bonds, providing medical technology solutions, engaging in healthcare project development, offering medical consultation, and other diverse medical services. Established in 1971, the entity was known as Mega Medical Technology Limited until its rebranding in January 2018, and its headquarters are located in Central, Hong Kong.
Technical Analysis
Shandong Weigao Group Medical Polymer Co
―
―
PW Medtech Group Ltd.
―
Shanghai Kindly Medical Instruments Co., Ltd. Class H
―
Shanghai Conant Optical Co. Ltd. Class H
―